Transient Mood Elevation Without a Manic Switch: Goldenseal-Augmented Oral Glutamatergic Regimen in Bipolar Depression With Comorbid Obsessive-Compulsive Disorder (OCD).
- 2026-02-24
- Cureus 18(2)
- Ngo Cheung
- PubMed: 41756342
- DOI: 10.7759/cureus.104209
Study Design
- Type
- Case Report
- Population
- a 32-year-old man with bipolar depression and health-related ruminations
- Methods
- Single case report: patient added 600 mg goldenseal (CYP2D6 inhibitor) to his existing regimen of mood stabilisers (valproate, low-dose aripiprazole, pregabalin, and Deanxit) and an over-the-counter mix of dextromethorphan, piracetam, and L-glutamine.
- Duration
- ten days
- Funding
- Unclear
Research Insights
Ten days after he added 600 mg of the herbal CYP2D6 inhibitor goldenseal, thought to slow the breakdown of dextromethorphan, he reported a clear lift in energy, mood, and work performance, with no signs of hypomania
- Effect
- Beneficial
- Effect size
- Moderate
- Dose
- 600 mg
Ten days after he added 600 mg of the herbal CYP2D6 inhibitor goldenseal, thought to slow the breakdown of dextromethorphan, he reported a clear lift in energy, mood, and work performance, with no signs of hypomania
- Effect
- Beneficial
- Effect size
- Moderate
- Dose
- 600 mg
Ten days after he added 600 mg of the herbal CYP2D6 inhibitor goldenseal, thought to slow the breakdown of dextromethorphan, he reported a clear lift in energy, mood, and work performance, with no signs of hypomania
- Effect
- Beneficial
- Effect size
- Moderate
- Dose
- 600 mg
Ten days after he added 600 mg of the herbal CYP2D6 inhibitor goldenseal, thought to slow the breakdown of dextromethorphan, he reported a clear lift in energy, mood, and work performance, with no signs of hypomania
- Effect
- Beneficial
- Effect size
- Moderate
- Dose
- 600 mg
Adverse Events Reported
he had no side effects
- Finding
- Reported